Phio Pharmaceuticals Corp (PHIO)
0.75
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
0.75
0.00 (0.00%)
Pre-Market: 20:00
Phio Pharmaceuticals Cash from Operations (TTM): -10.05M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -10.05M |
December 31, 2023 | -10.75M |
September 30, 2023 | -11.08M |
June 30, 2023 | -11.71M |
March 31, 2023 | -11.37M |
December 31, 2022 | -12.13M |
September 30, 2022 | -11.90M |
June 30, 2022 | -11.24M |
March 31, 2022 | -12.06M |
December 31, 2021 | -11.86M |
September 30, 2021 | -12.01M |
June 30, 2021 | -11.12M |
March 31, 2021 | -9.892M |
December 31, 2020 | -8.802M |
September 30, 2020 | -8.725M |
June 30, 2020 | -8.745M |
March 31, 2020 | -8.646M |
December 31, 2019 | -8.645M |
September 30, 2019 | -7.845M |
June 30, 2019 | -7.861M |
March 31, 2019 | -7.788M |
December 31, 2018 | -7.52M |
September 30, 2018 | -7.975M |
June 30, 2018 | -8.165M |
March 31, 2018 | -8.622M |
Date | Value |
---|---|
December 31, 2017 | -9.514M |
September 30, 2017 | -8.685M |
June 30, 2017 | -8.091M |
March 31, 2017 | -7.634M |
December 31, 2016 | -7.76M |
September 30, 2016 | -7.97M |
June 30, 2016 | -8.33M |
March 31, 2016 | -8.27M |
December 31, 2015 | -7.317M |
September 30, 2015 | -7.33M |
June 30, 2015 | -7.133M |
March 31, 2015 | -7.35M |
December 31, 2014 | -7.758M |
September 30, 2014 | -7.565M |
June 30, 2014 | -7.524M |
March 31, 2014 | -7.563M |
December 31, 2013 | -6.311M |
September 30, 2013 | -6.059M |
June 30, 2013 | -5.591M |
March 31, 2013 | -4.981M |
December 31, 2012 | -5.062M |
September 30, 2012 | -6.722M |
June 30, 2012 | -7.582M |
March 31, 2012 | -8.171M |
December 31, 2011 | -9.989M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-12.13M
Minimum
Dec 2022
-7.845M
Maximum
Sep 2019
-10.32M
Average
-10.92M
Median
Cash from Operations (TTM) Benchmarks
Apyx Medical Corp | -9.709M |
Nortech Systems Inc | 2.879M |
Pyxis Oncology Inc | -64.58M |
X4 Pharmaceuticals Inc | -103.60M |
Monogram Technologies Inc | -14.31M |